Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dittmer, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dittmer, D. P.
[Cancer Research 63, 2010-2015, May 1, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

Transcription Profile of Kaposi’s Sarcoma-associated Herpesvirus in Primary Kaposi’s Sarcoma Lesions as Determined by Real-Time PCR Arrays1

Dirk P. Dittmer2

Department of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104

Kaposi’s sarcoma (KS) is the signature pathology of AIDS. KS-associated herpesvirus (KSHV/HHV-8) is causally linked to KS. Here, we report the first complete profile of KSHV transcription in primary KS lesions using a novel, real-time PCR array. The KSHV latency I mRNAs [latency-associated nuclear antigen (LANA)/orf73, v-cyclin/orf72, and v-FLIP/orf71] were invariably present in all biopsies. Yet, viral lytic mRNAs were detectable in only a subset of tumors. Interestingly, there was a difference in the expression pattern of the viral IFN-regulatory factors (vIRFs) encoded by KSHV. The vIRF-1/K9 clustered with LANA in KS, in contrast to its homologue, vIRF-3/LANA-2, which is transcribed only in KSHV-associated lymphomas. This suggests that the various vIRFs encoded by KSHV are important for KSHV latency as well as KS tumorigenesis and that their redundancy may be explained in part by a tissue-specific regulation. Clinical KSHV transcriptional profiling as described here will prove useful for the identification of KS tumor markers for diagnosis and as potential drug targets. Stratification by KSHV lytic transcription can identify lesions with a high percentage of lytically infected cells, which may respond to antiviral drugs.




This article has been cited by other articles:


Home page
J. Virol.Home page
P.-C. Chang and M. Li
Kaposi's Sarcoma-Associated Herpesvirus K-Cyclin Interacts with Cdk9 and Stimulates Cdk9-Mediated Phosphorylation of p53 Tumor Suppressor
J. Virol., January 1, 2008; 82(1): 278 - 290.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Lubyova, M. J. Kellum, J. A. Frisancho, and P. M. Pitha
Stimulation of c-Myc Transcriptional Activity by vIRF-3 of Kaposi Sarcoma-associated Herpesvirus
J. Biol. Chem., November 2, 2007; 282(44): 31944 - 31953.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. J. Vart, L. L. Nikitenko, D. Lagos, M. W.B. Trotter, M. Cannon, D. Bourboulia, F. Gratrix, Y. Takeuchi, and C. Boshoff
Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 and G-Protein-Coupled Receptor Regulate Angiopoietin-2 Expression in Lymphatic Endothelial Cells
Cancer Res., May 1, 2007; 67(9): 4042 - 4051.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-H. Sin, D. Roy, L. Wang, M. R. Staudt, F. D. Fakhari, D. D. Patel, D. Henry, W. J. Harrington Jr, B. A. Damania, and D. P. Dittmer
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Blood, March 1, 2007; 109(5): 2165 - 2173.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. E. Petre, S.-H. Sin, and D. P. Dittmer
Functional p53 Signaling in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas: Implications for Therapy
J. Virol., February 15, 2007; 81(4): 1912 - 1922.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Lagos, M. W. B. Trotter, R. J. Vart, H.-W. Wang, N. C. Matthews, A. Hansen, O. Flore, F. Gotch, and C. Boshoff
Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells
Blood, February 15, 2007; 109(4): 1550 - 1558.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview
J. Gen. Virol., July 1, 2006; 87(7): 1781 - 1804.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F.-Q. An, H. M. Folarin, N. Compitello, J. Roth, S. L. Gerson, K. R. McCrae, F. D. Fakhari, D. P. Dittmer, and R. Renne
Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo.
J. Virol., May 1, 2006; 80(10): 4833 - 4846.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Wang, D. P. Dittmer, C. C. Tomlinson, F. D. Fakhari, and B. Damania
Immortalization of Primary Endothelial Cells by the K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus.
Cancer Res., April 1, 2006; 66(7): 3658 - 3666.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Sarek, A. Jarviluoma, and P. M. Ojala
KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas
Blood, January 15, 2006; 107(2): 725 - 732.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Hilscher, W. Vahrson, and D. P. Dittmer
Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability
Nucleic Acids Res., November 27, 2005; 33(21): e182 - e182.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Chang, D. P. Dittmer, S.-Y. Chul, Y. Hong, and J. U. Jung
Role of Notch Signal Transduction in Kaposi's Sarcoma-Associated Herpesvirus Gene Expression
J. Virol., November 15, 2005; 79(22): 14371 - 14382.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. P. Dittmer, C. M. Gonzalez, W. Vahrson, S. M. DeWire, R. Hines-Boykin, and B. Damania
Whole-Genome Transcription Profiling of Rhesus Monkey Rhadinovirus
J. Virol., July 1, 2005; 79(13): 8637 - 8650.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Kurokawa, S. K. Ghosh, J. C. Ramos, A. M. Mian, N. L. Toomey, L. Cabral, D. Whitby, G. N. Barber, D. P. Dittmer, and W. J. Harrington Jr
Azidothymidine inhibits NF-{kappa}B and induces Epstein-Barr virus gene expression in Burkitt lymphoma
Blood, July 1, 2005; 106(1): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Seo, J. Park, and J. Choe
Kaposi's Sarcoma-Associated Herpesvirus Viral IFN Regulatory Factor 1 Inhibits Transforming Growth Factor-{beta} Signaling
Cancer Res., March 1, 2005; 65(5): 1738 - 1747.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Jarviluoma, S. Koopal, S. Rasanen, T. P. Makela, and P. M. Ojala
KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas
Blood, November 15, 2004; 104(10): 3349 - 3354.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Germi, P. Morand, K. Brengel-Pesce, S. Fafi-Kremer, O. Genoulaz, C. Ginevra, M. Ballout, G. Bargues, and J.-M. Seigneurin
Quantification of gp350/220 Epstein-Barr Virus (EBV) mRNA by Real-Time Reverse Transcription-PCR in EBV-Associated Diseases
Clin. Chem., October 1, 2004; 50(10): 1814 - 1817.
[Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Staudt, Y. Kanan, J. H. Jeong, J. F. Papin, R. Hines-Boykin, and D. P. Dittmer
The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo
Cancer Res., July 15, 2004; 64(14): 4790 - 4799.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. P. Pozharskaya, L. L. Weakland, J. C. Zimring, L. T. Krug, E. R. Unger, A. Neisch, H. Joshi, N. Inoue, and M. K. Offermann
Short Duration of Elevated vIRF-1 Expression during Lytic Replication of Human Herpesvirus 8 Limits Its Ability To Block Antiviral Responses Induced by Alpha Interferon in BCBL-1 Cells
J. Virol., June 15, 2004; 78(12): 6621 - 6635.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Canham and S. J. Talbot
A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA
J. Gen. Virol., June 1, 2004; 85(6): 1363 - 1369.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Damania, J. H. Jeong, B. S. Bowser, S. M. DeWire, M. R. Staudt, and D. P. Dittmer
Comparison of the Rta/Orf50 Transactivator Proteins of Gamma-2-Herpesviruses
J. Virol., May 15, 2004; 78(10): 5491 - 5499.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. F. Papin, W. Vahrson, and D. P. Dittmer
SYBR Green-Based Real-Time Quantitative PCR Assay for Detection of West Nile Virus Circumvents False-Negative Results Due to Strain Variability
J. Clin. Microbiol., April 1, 2004; 42(4): 1511 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. D. Schmittgen, J. Jiang, Q. Liu, and L. Yang
A high-throughput method to monitor the expression of microRNA precursors
Nucleic Acids Res., February 25, 2004; 32(4): e43 - e43.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.